|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, November 25, 2016 ) The weight loss and obesity management market includes products, services and therapies for reducing or managing weight in overweight and obese patients. According to the World Health Organization (WHO) definition, body mass index (BMI) greater than or...
Source: EmailWire.com
 (Medical-NewsWire.com, November 25, 2016 ) Clinical trials are research studies performed on humans to gain specific information about biomedical interventions such as novel vaccines, devices, treatments and drugs and thereby generating safety data. Clinical trials are regulated by health authorities...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Kallikrein Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Kallikrein Inhibitors. The Publisher's Report covers the product profiles in various stages...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Heat Shock Protein (Hsp) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Heat Shock Protein (Hsp) Inhibitors. The Publisher's Report covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Non-Structural Protein 5A Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Non-Structural Protein 5A Inhibitors. The Publisher's Report covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) "Myosin Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Myosin Inhibitors. The DelveInsight's Report covers the product profiles in various stages of development including...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Metal Ion Chelators-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Metal Ion Chelators. The Publisher's Report covers the product profiles in various stages of...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Prostacyclin (Prostaglandin I2) Receptor Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Prostacyclin (Prostaglandin I2) Receptor Agonists. The Publisher's...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Penicillin-Binding Proteins (PBPs) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Penicillin-Binding Proteins (PBPs) Inhibitors. The Publisher's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Viral Protease Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Viral Protease Inhibitors. The Publisher's Report covers the product profiles in various...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Aurora Kinase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Aurora Kinase Inhibitors. The Publisher's Report covers the product profiles in various...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Anti-CD105 Antibody-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD105 Antibody. The Publisher's Report covers the product profiles in various stages of...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "CysLT subtype 1 receptor (CysLT1) Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CysLT subtype 1 receptor (CysLT1) Antagonists. The Publisher's Report...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "CD 33 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the CD 33 Inhibitors. The Publisher's Report covers the product profiles in various stages of development...
Source: EmailWire.com
 (Medical-NewsWire.com, November 24, 2016 ) Publisher's, "Bradykinin Receptor B2 Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Bradykinin Receptor B2 Antagonists. The Publisher's Report covers the product...
Source: EmailWire.com
|
|
|
|
